SCHEDULE 14A
                    Proxy Statement Pursuant to Section 14(a)
            of the Securities Exchange Act of 1934 (Amendment No. __)


Filed by the Registrant    [  ]

Filed by a Party other than the Registrant    [x]

Check the appropriate box:

[  ]     Preliminary Proxy Statement
[  ]     Confidential, for Use of the Commission Only
                (as permitted by Rule 14a-6(e)(2))
[  ]     Definitive Proxy Statement
[  ]     Definitive Additional Materials
[X]      Soliciting Material Pursuant to ss. 240.14a-12

                             Mylan Laboratories Inc.

                (Name of Registrant as Specified In Its Charter)

                                 Carl C. Icahn,
                   Barberry Corp., Hopper Investments LLC and
                         High River Limited Partnership


    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (check the appropriate box):

[X] No fee required.

[ ] Fee computed on table below per Exchange Act Rule 14a-6(i)(4) and 0-11.

         1) Title of each class of securities to which transaction applies:



         2) Aggregate number of securities to which transaction applies:



         3) Per unit price or other  underlying  value of  transaction  computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee
is calculated and state how it was determined):



         4) Proposed maximum aggregate value of transaction:



         5) Total fee paid:



[  ]     Fee paid previously with preliminary materials.

[ ] Check box if any part of the fee is offset as provided by Exchange  Act Rule
0-11(a)(2)  and  identify  the  filing  for  which the  offsetting  fee was paid
previously.  Identify the previous filing by registration  statement  number, or
the Form or Schedule and the date of its filing.

         1) Amount Previously Paid:



         2) Form, Schedule or Registration Statement No.:



         3) Filing Party:



         4) Date Filed:







         On February 25, 2005,  Carl C. Icahn has issued a press release,  which
is attached hereto as Exhibit A.

SECURITY  HOLDERS ARE ADVISED TO READ THE PROXY  STATEMENT  AND OTHER  DOCUMENTS
RELATED TO  SOLICITATION  OF PROXIES BY MR.  ICAHN AND HIS  AFFILIATES  FROM THE
STOCKHOLDERS OF MYLAN  LABORATORIES  INC. FOR USE AT ITS SPECIAL MEETING AND ITS
ANNUAL  MEETING,  IN EACH CASE, (A) WHEN AND IF THEY BECOME  AVAILABLE,  BECAUSE
THEY WILL CONTAIN IMPORTANT  INFORMATION,  INCLUDING INFORMATION RELATING TO THE
PARTICIPANTS IN ANY SUCH PROXY  SOLICITATION,  AND (B) WHEN AND IF COMPLETED,  A
DEFINITIVE  PROXY  STATEMENT  AND A FORM  OF  PROXY  WHICH  WILL  BE  MAILED  TO
STOCKHOLDERS  OF MYLAN  LABORATORIES  INC. AND WILL BE AVAILABLE AT NO CHARGE AT
THE  SECURITIES  AND  EXCHANGE   COMMISSION'S  WEBSITE  AT   HTTP://WWW.SEC.GOV.
INFORMATION  RELATING TO THE PARTICIPANTS IN A PROXY  SOLICITATION IN CONNECTION
WITH THE SPECIAL  MEETING IS CONTAINED IN THE  SCHEDULE  14A, AS AMENDED,  FIRST
FILED  BY MR.  ICAHN  AND  HIS  AFFILIATES  WITH  THE  SECURITIES  AND  EXCHANGE
COMMISSION  ON OCTOBER 14, 2004 WITH  RESPECT TO MYLAN  LABORATORIES  INC.  THAT
SCHEDULE 14A IS CURRENTLY  AVAILABLE AT NO CHARGE ON THE SECURITIES AND EXCHANGE
COMMISSION'S WEBSITE.







                                                                      EXHIBIT A


                              FOR IMMEDIATE RELEASE
             CARL C. ICAHN INTENDS TO NOMINATE A SLATE OF DIRECTORS
                   FOR THE BOARD OF MYLAN LABORATORIES, INC.


New York, New York, February 25, 2005
Contact:  Susan Gordon (212) 702-4309

                  Carl C. Icahn  announced  today that his  affiliated  company,
High River Limited Partnership,  intends to nominate a slate of eleven directors
to the board of Mylan  Laboratories,  Inc.  and to notify  Mylan of its proposed
nominees on or before Monday, February 28, 2005.

SECURITY  HOLDERS ARE ADVISED TO READ THE PROXY  STATEMENT  AND OTHER  DOCUMENTS
RELATED TO  SOLICITATION  OF PROXIES BY MR.  ICAHN AND HIS  AFFILIATES  FROM THE
STOCKHOLDERS OF MYLAN  LABORATORIES  INC. FOR USE AT ITS SPECIAL MEETING AND ITS
ANNUAL  MEETING,  IN EACH CASE, (A) WHEN AND IF THEY BECOME  AVAILABLE,  BECAUSE
THEY WILL CONTAIN IMPORTANT  INFORMATION,  INCLUDING INFORMATION RELATING TO THE
PARTICIPANTS IN ANY SUCH PROXY  SOLICITATION,  AND (B) WHEN AND IF COMPLETED,  A
DEFINITIVE  PROXY  STATEMENT  AND A FORM  OF  PROXY  WHICH  WILL  BE  MAILED  TO
STOCKHOLDERS  OF MYLAN  LABORATORIES  INC. AND WILL BE AVAILABLE AT NO CHARGE AT
THE  SECURITIES  AND  EXCHANGE   COMMISSION'S  WEBSITE  AT   HTTP://WWW.SEC.GOV.
INFORMATION  RELATING TO THE PARTICIPANTS IN A PROXY  SOLICITATION IN CONNECTION
WITH THE SPECIAL  MEETING IS CONTAINED IN THE  SCHEDULE  14A, AS AMENDED,  FIRST
FILED  BY MR.  ICAHN  AND  HIS  AFFILIATES  WITH  THE  SECURITIES  AND  EXCHANGE
COMMISSION  ON OCTOBER 14, 2004 WITH  RESPECT TO MYLAN  LABORATORIES  INC.  THAT
SCHEDULE 14A IS CURRENTLY  AVAILABLE AT NO CHARGE ON THE SECURITIES AND EXCHANGE
COMMISSION'S WEBSITE.